Literature DB >> 2843668

Topoisomerase I is preferentially associated with isolated replicating simian virus 40 molecules after treatment of infected cells with camptothecin.

J J Champoux1.   

Abstract

Detergent extraction of simian virus 40 (SV40) DNA from infected monkey CV-1 cells, after a brief exposure to the drug camptothecin, yields covalent complexes between topoisomerase I and DNA that band with reduced buoyant densities in CsCl. The following lines of evidence indicate that the enzyme is preferentially associated with SV40 replicative intermediates. First, the percentage of the isolated labeled viral DNA that exhibited a reduced buoyant density is inversely proportional to the length of the labeling period and approximately parallels the percentage of replicative intermediates for each labeling time (5 to 60 min). Second, after labeling for 60 min, the isolated low-density material was found to be enriched for replicative intermediates as measured by sedimentation in neutral sucrose. Third, analysis of extracted viral DNA by equilibrium centrifugation in CsCl-propidium diiodide gradients that separate replicating molecules from completed form I DNA revealed that camptothecin pretreatment specifically caused the linkage of topoisomerase I to replicating molecules. In addition, analysis of the low-density material obtained under conditions when only the newly synthesized strands of the replicative intermediates were labeled showed that the enzyme was associated almost exclusively with the parental strands. Taken together, these observations indicate that topoisomerase I is involved in DNA replication, and they are consistent with the hypothesis that the enzyme provides swivels to allow the helix to unwind. The observed bias in the distribution of topoisomerase I on intracellular SV40 DNA could be the result of rapid encapsidation of replicated molecules that precludes the association of topoisomerase I with the DNA or, alternatively, the result of a specific association of the enzyme with replicative intermediates.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2843668      PMCID: PMC253510          DOI: 10.1128/JVI.62.10.3675-3683.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  DNA replication in SV40-infected cells. 8. The distribution of replicating molecules at different stages of replication in SV40-infected cells.

Authors:  A Mayer; A J Levine
Journal:  Virology       Date:  1972-11       Impact factor: 3.616

2.  An activity from mammalian cells that untwists superhelical DNA--a possible swivel for DNA replication (polyoma-ethidium bromide-mouse-embryo cells-dye binding assay).

Authors:  J J Champoux; R Dulbecco
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

3.  Replicating SV40 molecules containing closed circular template DNA strands.

Authors:  R Jaenisch; A Mayer; A Levine
Journal:  Nat New Biol       Date:  1971-09-15

4.  DNA replication in SV40 infected cells. I. Analysis of replicating SV40 DNA.

Authors:  A J Levine; H S Kang; F E Billheimer
Journal:  J Mol Biol       Date:  1970-06-14       Impact factor: 5.469

5.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

6.  Studies on camptothecin-induced degradation and apparent reaggregation of DNA from L1210 cells.

Authors:  A Spataro; D Kessel
Journal:  Biochem Biophys Res Commun       Date:  1972-08-07       Impact factor: 3.575

7.  Intracellular degradation of HeLa and adenovirus type 2 DNA induced by camptothecin.

Authors:  M S Horwitz; S B Horwitz
Journal:  Biochem Biophys Res Commun       Date:  1971-11-05       Impact factor: 3.575

8.  Studies on camptothecin. I. Effects of nucleic acid and protein synthesis.

Authors:  S B Horwitz; C K Chang; A P Grollman
Journal:  Mol Pharmacol       Date:  1971-11       Impact factor: 4.436

9.  Inactivating and mutagenic effects of nitrosoguanidine on simian virus 40.

Authors:  P Tegtmeyer; C Dohan; C Reznikoff
Journal:  Proc Natl Acad Sci U S A       Date:  1970-07       Impact factor: 11.205

10.  Structure of replicating simian virus 40 deoxyribonucleic acid molecules.

Authors:  E D Sebring; T J Kelly; M M Thoren; N P Salzman
Journal:  J Virol       Date:  1971-10       Impact factor: 5.103

View more
  11 in total

1.  Topoisomerase I is preferentially associated with normal SV40 replicative intermediates, but is associated with both replicating and nonreplicating SV40 DNAs which are deficient in histones.

Authors:  J J Champoux
Journal:  Nucleic Acids Res       Date:  1992-07-11       Impact factor: 16.971

2.  Autonomous parvovirus DNA replication requires topoisomerase I and its activity is increased during infection.

Authors:  M L Gu; S L Rhode
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

3.  Topoisomerase I-mediated integration of hepadnavirus DNA in vitro.

Authors:  H P Wang; C E Rogler
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

4.  Mechanism and specificity of DNA strand exchange catalyzed by vaccinia DNA topoisomerase type I.

Authors:  Mary R Stahley; James T Stivers
Journal:  Biochemistry       Date:  2010-04-06       Impact factor: 3.162

5.  Mapping in vivo topoisomerase I sites on simian virus 40 DNA: asymmetric distribution of sites on replicating molecules.

Authors:  S E Porter; J J Champoux
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

6.  Topoisomerase I sites cluster asymmetrically at the ends of the simian virus 40 core origin of replication.

Authors:  S Tsui; M E Anderson; P Tegtmeyer
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

7.  Human topoisomerase I promotes initiation of simian virus 40 DNA replication in vitro.

Authors:  P W Trowbridge; R Roy; D T Simmons
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

8.  The basis for camptothecin enhancement of DNA breakage by eukaryotic topoisomerase I.

Authors:  S E Porter; J J Champoux
Journal:  Nucleic Acids Res       Date:  1989-11-11       Impact factor: 16.971

9.  Specific cleavage of chicken alpha A-globin and human c-Ha-ras genes by two molecular forms of calf thymus topoisomerase I.

Authors:  I B Bronstein; I I Gromova; S V Razin
Journal:  Mol Cell Biochem       Date:  1991-03-13       Impact factor: 3.396

10.  Human immunodeficiency virus type 1 reverse transcriptase: enhancement of activity by interaction with cellular topoisomerase I.

Authors:  H Takahashi; M Matsuda; A Kojima; T Sata; T Andoh; T Kurata; K Nagashima; W W Hall
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.